Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena T Hogberg

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Cellular Neuroscience|March 11, 2020
Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain ModelXiali Zhong, Georgina Harris, Lena Smirnova, et al.
Neurotoxicology|June 4, 2026
Prioritizing chemicals for developmental neurotoxicity by integrating data from a new approach methods (NAMs) battery covering key cellular events in neurodevelopmentLaura A Hall, Jui-Hua Hsieh, Skylar W Marvel, et al.
ALTEX|November 25, 2016
A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicityDavid Pamies, Paula Barreras, Katharina Block, et al.
ALTEX|July 26, 2016
Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and useMichael Aschner, Sandra Ceccatelli, Mardas Daneshian, et al.
Cells|November 11, 2022
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19Helena T Hogberg, Ann Lam, Elan Ohayon, et al.
ALTEX|December 15, 2024
State of the science on assessing developmental neurotoxicity using new approach methodsSusan J Debad, Jason Aungst, Kelly Carstens, et al.
F1000Research|May 11, 2026
Methods2AOP: A Collaboration to Strengthen the Integration of Test Methods into the Adverse Outcome Pathway FrameworkAgnes L Karmaus, William Bisson, Albert Braeuning, et al.
ALTEX|February 28, 2018
Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicityAnna Bal-Price, Helena T Hogberg, Kevin M Crofton, et al.
ALTEX|July 23, 2019
Corrigendum to Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicityAnna Bal-Price, Helena T Hogberg, Kevin M Crofton, et al.
Toxicology and Applied Pharmacology|February 16, 2018
Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposesEllen Fritsche, Philippe Grandjean, Kevin M Crofton, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Cellular Neuroscience|March 11, 2020
Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain ModelXiali Zhong, Georgina Harris, Lena Smirnova, et al.
Neurotoxicology|June 4, 2026
Prioritizing chemicals for developmental neurotoxicity by integrating data from a new approach methods (NAMs) battery covering key cellular events in neurodevelopmentLaura A Hall, Jui-Hua Hsieh, Skylar W Marvel, et al.
ALTEX|November 25, 2016
A human brain microphysiological system derived from induced pluripotent stem cells to study neurological diseases and toxicityDavid Pamies, Paula Barreras, Katharina Block, et al.
ALTEX|July 26, 2016
Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and useMichael Aschner, Sandra Ceccatelli, Mardas Daneshian, et al.
Cells|November 11, 2022
The Adverse Outcome Pathway Framework Applied to Neurological Symptoms of COVID-19Helena T Hogberg, Ann Lam, Elan Ohayon, et al.
ALTEX|December 15, 2024
State of the science on assessing developmental neurotoxicity using new approach methodsSusan J Debad, Jason Aungst, Kelly Carstens, et al.
F1000Research|May 11, 2026
Methods2AOP: A Collaboration to Strengthen the Integration of Test Methods into the Adverse Outcome Pathway FrameworkAgnes L Karmaus, William Bisson, Albert Braeuning, et al.
ALTEX|February 28, 2018
Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicityAnna Bal-Price, Helena T Hogberg, Kevin M Crofton, et al.
ALTEX|July 23, 2019
Corrigendum to Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicityAnna Bal-Price, Helena T Hogberg, Kevin M Crofton, et al.
Toxicology and Applied Pharmacology|February 16, 2018
Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposesEllen Fritsche, Philippe Grandjean, Kevin M Crofton, et al.
Pageof 7